IL6 and cancer: This inflammatory cascade, marked by a suite of indicators such as neutrophilia, the derived neutrophil-to-lymphocyte ratio (dNLR), c-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha), is essential not only to the innate immune defense against COVID-19, but also in the context of cancer [11,12].